Active Recombinant Human SOSTDC1

• Cat.No.: SOSTDC1-691H
• Product Overview: Recombinant Human SOSTDC1 (Accession # NP_056279) Phe24-Ser206, fused with an N-terminal Met, was produced in E. coli.

Specification

• Source: E. coli
• Species: Human
• Predicted N Terminal: Met
• Form: Lyophilized from a 0.2 µm filtered solution in HCl.
• Bio-activity: Measured by its binding ability in a functional ELISA.When Recombinant Human (rh) USAG1 is coated at 2 µg/mL (100 µL/well), the concentration of rhLRP-6 Fc Chimera that produces 50% of the optimal binding response is found to be approximately 0.4 - 2 µg/mL.
• Molecular Mass: Recombinant Human SOSTDC1, Met-tagged has a calculated MW of 20.9 kDa. In SDS-PAGE migrates as 21 kDa, reducing conditions.
• Protein length: Phe24-Ser206
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: SOSTDC1 sclerostin domain containing 1 [ Homo sapiens ]
• Official Symbol: SOSTDC1
• Synonyms: SOSTDC1; sclerostin domain containing 1; sclerostin domain-containing protein 1; DKFZp564D206; ectodin; USAG1; ectodermal BMP inhibitor; cystine-knot containing secreted protein; uterine sensitization-associated protein-1; CDA019; ECTODIN
• Gene ID: 25928
• mRNA Refseq: NM_015464
• Protein Refseq: NP_056279
• MIM: 609675
• UniProt ID: Q6X4U4
• Chromosome Location: 7p21.2